Overview
The Shaji Kumar Hematology Research Award supports innovative research in hematologic malignancies and is directly aligned with the Summit on Hematologic Cancers. Named in honor of Dr. Shaji Kumar, this award recognizes early-career investigators pursuing bold ideas that advance understanding and treatment of blood cancers.
Award Amount: Up to $50,000 per project
Award Focus
Projects should address:
- Translational or clinical research in hematologic malignancies
- Novel therapeutic strategies or biomarkers
- Mechanistic, outcomes, or health services research
- Studies addressing unmet needs in blood cancers
Application Pathway
1. Abstract Submission (via Summit on Hematologic Cancers)
Applicants must submit an abstract based on completed or ongoing research for presentation at the Summit on Hematologic Cancers.
(Abstract Submission Deadline: August 15, 2026)
Submit an Abstract to the Summit on Hematologic Cancers
2. Research Proposal
First authors of accepted abstracts are invited to submit a separate hematology research proposal.
- Only first authors of accepted abstracts are eligible to submit a proposal, and only early-career hematology/oncology faculty (5 years or less) or fellows are eligible for the research award funding.
- The proposal may be entirely different from the abstracted work.
- Limit one proposal per person.
3. Impact Pitch at the Summit on Hematologic Cancers
Finalists present their proposals live during the Impact Pitch session held as part of the Summit on Hematologic Cancers.
Eligibility
- First authors of accepted abstracts, AND
- Early-career (within 5 years) hematologists or hematology/oncology fellows
Funding and Expectations
- Competitive research funding of up to $50,000 per project
- Up to 15% overhead costs permitted
- Awardees acknowledge Binaytara's support in publications and presentations
- Progress and outcomes presented at a future Binaytara’s Summit on Hematologic Cancers
Explore Current Research Award Opportunities
